UCM-03025

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameUCM-03025
Drug Alias Namemonoacylglycerol lipase inhibitors (Universidad Complutense de Madrid/University of Umea/Cajal Institute)UCM-03025
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMonoglyceride lipase inhibitors
TargetsMonoglyceride lipase
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenSpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLa Universidad Complutense de Madrid
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCajal InstituteUmea UniversityLa Universidad Complutense de Madrid
Active IndicationsN/A
Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A